BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1728949)

  • 1. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2).
    Farag S; Challis J; White J; Garson OM
    Cancer Genet Cytogenet; 1992 Jan; 58(1):48-51. PubMed ID: 1728949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
    Shi G; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
    Testoni N; Zaccaria A; Celso B; Tura S
    Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
    Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
    Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute nonlymphocytic leukemia: evidence of clonogenic cells in peripheral blood in early complete remission.
    Castagnola C; Bonfichi M; Colombo A; Bernasconi P; Bernasconi C
    Acta Haematol; 1989; 82(4):210-2. PubMed ID: 2511724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report.
    Testoni N; Zaccaria A; Celso B; Tassinari A; Rosti G; Tura S
    Haematologica; 1989; 74(6):595-9. PubMed ID: 2628243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study Group.
    Bishop JF; Matthews JP; Young G; Szer J; Joshua DE; Dodds A; Laidlaw CR; Cobcroft R; Herrman R; Ma D
    Leuk Lymphoma; 1994 Sep; 15(1-2):79-84. PubMed ID: 7858505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation.
    Hamamoto K; Hashimoto-Ninomiya A; Kishimoto Y; Kimura T; Fujitake H; Yasunaga K; Horiike S
    Cancer Genet Cytogenet; 1994 May; 74(1):35-9. PubMed ID: 8194045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [8;21 translocation acute myelocytic leukemia developing in the second trimester of pregnancy with successful delivery].
    Nakayama M; Takata M; Kato M; Shikoshi K; Umeda M; Tanaka M; Hirakawa S
    Rinsho Ketsueki; 1996 Nov; 37(11):1265-70. PubMed ID: 8960659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction failures in childhood acute nonlymphocytic leukemia: etoposide/5-azacytidine for cases refractory to daunorubicin/cytarabine.
    Kalwinsky DK; Dahl GV; Mirro J; Jackson CW; Look AT
    Med Pediatr Oncol; 1986; 14(5):245-50. PubMed ID: 2431255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia.
    Nagai S; Nannya Y; Takahashi T; Kurokawa M
    Ann Hematol; 2010 Jul; 89(7):741-2. PubMed ID: 19904535
    [No Abstract]   [Full Text] [Related]  

  • 14. Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Fujimura T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Iwabuchi A; Kodama A; Toyama K
    Cancer Genet Cytogenet; 1993 Jul; 68(2):143-6. PubMed ID: 8353806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
    Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
    Toyosawa M; Shinohara K; Ariyoshi K; Ando T; Kobayashi M; Hikiji K
    Rinsho Ketsueki; 1997 Jan; 38(1):33-40. PubMed ID: 9028159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double minute chromosomes (DMs) in a case of acute myelocytic leukemia (M2: FAB classification)].
    Oguma N; Maehama S; Dohy H; Takimoto Y; Kamada N; Kuramoto A; Tanaka K; Mandai K; Tahara E
    Rinsho Ketsueki; 1984 Jun; 25(6):856-63. PubMed ID: 6592372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.